As of June 6, 2025, Genertec Universal Medical Group Co Ltd (2666.HK) reports a ROE (Return on Equity) of 11.16%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Genertec Universal Medical Group Co Ltd's ROE (Return on Equity)
Over recent years, Genertec Universal Medical Group Co Ltd's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | 11.16% |
| 2023-12-31 | 12.16% |
| 2022-12-31 | 12.53% |
| 2021-12-31 | 13.19% |
| 2020-12-31 | 14.06% |
This slight downward trend highlights how Genertec Universal Medical Group Co Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Genertec Universal Medical Group Co Ltd's ROE (Return on Equity) to Peers
To better understand Genertec Universal Medical Group Co Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Genertec Universal Medical Group Co Ltd (2666.HK) | 11.16% |
| Yihua Healthcare Co Ltd (000150.SZ) | 56.23% |
| Solasto Corp (6197.T) | 17.46% |
| E-House (China) Enterprise Holdings Ltd (2048.HK) | 16.29% |
| S Enjoy Service Group Co Ltd (1755.HK) | 15.33% |
| Poly Property Services Co Ltd (6049.HK) | 15.19% |
Compared to its competitors, Genertec Universal Medical Group Co Ltd's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.